Pharma to join anti-aging…there goes the neighborhood

Ed Park, MD News 3 Comments

Just a brief note about pharma becoming interested in anti-aging. First, we assume that aging is a thing, and not just many things, then we assume that nature has nothing to offer because we can’t patent and own anything natural, then we invest hundreds of millions of dollars to earn a potential billions of dollars.

But if illness and aging are combated by a pharmacological solution, say a telomerase activator, then pharma has sown the seeds of its own demise. Just some food for thought…

Will Alex Zhavoronkov’s company cure aging “In silico” before porting it over to humanity? (Part 1)

Ed Park, MD a4m, dr ed park, interview 1 Comment

At the 2014 American Academy of Anti-Aging conference, I was pleased to interview and dine with the keynote speaker, Alex Zhavoronkov.  He is a visionary leader in business, research, and anti-aging.      In this 5:36 segment, we discuss his vision for anti-aging technologies to solve the problems of Social Security, Medicare, and the global economy.  We also discuss why …